Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline APOBEC3B deletion: results of the phase II AUROR studyResearch in context by Gwo Fuang Ho, Soo Chin Lee, Anita Zarina Bustam, Adlinda Alip, Nur Fadhlina Abdul Satar, Marniza Saad, Rozita Abdul Malik, Siew Eng Lim, Samuel G.W. Ow, Andrea Wong, Wan-Qin Chong, Yvonne L.E. Ang, Audrey Weng Yan Lee, Siti Norhidayu Hasan, Nabilah Tuan Zaid, Kian Boon Law, Yok Yong Toh, Hooi Chiao Tan, Bawani Selvam, Joanna Lim, Jia-Wern Pan, Soo Hwang Teo

Get full text